Abstract:Background and Aims: This study was aim to investigate the relationship between the four intron SNPs (rs3087404, rs2029167, rs2029166 and rs7296239) of SMUG1 and the susceptibility of cervical squamous cell carcinoma. Methods: Four SMUG1 intron SNPs (rs3087404, rs2029167, rs2029166 and rs7296239) were genotyped by MA-PCR in 400 CSCCs, 400 CIN III and 1200 controls. qRT-PCR and Western blot were used to detect the SMUG1 mRNA and protein expression. Results: Interestingly, we found that the homozygous GG of rs3087404 had a significantly increased risk of CIN III [OR=1.78(1.27-2.51), P=0.001] and CSCCs [OR=4.04(2.94-5.55), P=0.000]. The individuals with G allele or G carrier (AG+GG) at rs3087404 were at higher risk for CSCCs [OR=1.34 (1.04-1.71), P=0.022]. Similarly, the homozygous GG of rs2029167 also had an increased risk of CIN III [OR=2.56(1.91-3.43), P=0.000] and CSCCs [OR=4.05(3.02-5.44), P=0.000]. The individuals with G allele or G carrier (AG+GG) at rs2029167 were at higher risk for CINIII [OR=1.41(1.10-1.80), P=0.006] and CSCCs [OR=1.91 (1.48-2.47), P=0.000]. In HR-HPV positive group, both the homozygous GG of rs3087404 and the homozygous GG of rs2029167 had an increased risk to CIN III and CSCC. Stratified analysis of the number of sexual partners and the age of first sexual intercourse found that the rs3087404 (A/G) had a particularly high level of enrichment in the CIN III or CSCCs groups. About the rs2029167 (A/G), we only found a particularly high level of enrichment grouping by the number of sexual partners in the CIN III and CSCCs groups. Meanwhile, we also found that there is a correlation between the SNPs of SMUG1 rs3087404 (A/G) and rs2029167 (A/G) with tumor cell differentiation and family heredity. But we didn't find that there was an association between the deferent genotypes of SMUG1 rs2029166 and rs7296239 with SMUG1 gene mRNA or protein expression. During the linkage disequilibrium analysis between rs3087404 (A/G) and rs2029167 (A/G), the genotype with AA-GG [OR=3.14(1.95-5.05)], AG-GG [OR=2.45(1.58-3.89)], GG-AA [OR=2.24(1.28-3.90)] and GG-AG [OR=2.58(1.54-4.32)] significantly increased the risk of CIN III. More notably, this risk is much greater in CSCCs: AA-GG [OR=7.13(4.03-12.61)], AG-GG [OR=7.22(4.21-12.38)], GG-AA [OR=8.60(4.73-15.63)], GG-AG [OR=9.64(5.43-17.13)]. Additionally, most GG (rs3087404) genotypes were linkage GG-AG (44/77, 80/140) in the CIN III and CSCCs, while most GG (rs2029167) genotypes were linkage genotype AG-GG (79/145, 112/184) in the CIN III and CSCCs, respectively. Conclusions: These findings suggested that there was association between the two genetic polymorphisms of SMUG1 rs3087404(A/G) and rs2029167(A/G) with the susceptibility of CIN III and CSCCs, and there was a linkage disequilibrium between the rs3087404 with the rs2029167 in CIN III and CSCCs. This particular linkage disequilibrium can be used as predictive biomarkers of CIN III and CSCC.

Abstract A105: Genetic Variations in Sonic Pathway Genes As Predictors of Bladder Cancer Risk

Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer.

Abstract PR-09: Genetic Variations in the Sonic Hedgehog Pathway and Clinical Outcomes in Bladder Cancer

Correlation of Interleukin-10-1082G/A Single Nucleotide Polymorphism to the Susceptibility of Bladder Cancer

Genetic Variants in the Hedgehog Signaling Pathway Genes Are Associated with Gastric Cancer Risk in a Chinese Han Population

Association of Base Excision Repair Gene Hogg1 Ser326Cys Polymorphism with Susceptibility to Cervical Squamous Cell Carcinoma and High-Risk Human Papilloma Virus Infection in a Chinese Population.

Association of SMUG1 SNPs in Intron Region and Linkage Disequilibrium with Occurrence of Cervical Carcinoma and HPV Infection in Chinese Population

Hedgehog Gene Polymorphisms Are Associated with the Risk of Hirschsprung's Disease and Anorectal Malformation in a Chinese Population.

Genetic Variations In Regulator Of G-Protein Signaling (Rgs) Confer Risk Of Bladder Cancer

Genetic Variants in Cell Cycle Control Pathway Confer Susceptibility to Bladder Cancer

Evaluation Of Genetic Variants In Microrna-Related Genes And Risk Of Bladder Cancer

Genetic Variants in the Wnt/β-Catenin Signaling Pathway As Indicators of Bladder Cancer Risk.

HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer

Profiling of Genetic Variations in Inflammation Pathway Genes in Relation to Bladder Cancer Predisposition

Genetic Variations in Base Excision Repair Pathway and Risk of Bladder Cancer: A Case-Control Study in the United States

1242 GENETIC VARIATIONS IN REGULATOR OF G-PROTEIN SIGNALING GENES AS SUSCEPTIBILITY LOCI FOR BLADDER CANCER

Abstract 4843: Genetic Variants in Notch Signaling Pathway and Ovarian Cancer.

Abstract 1667: Pathway Analysis of Bladder Cancer Genome-Wide Association Study Identifies Several Novel Pathways Involved in Bladder Cancer Development

The Association of Rs710886 in Lncrna PCAT1 with Bladder Cancer Risk in a Chinese Population.

A functional polymorphism in RGS6 modulates the risk of bladder cancer.

Genetic Variations in the Transforming Growth Factor Beta Pathway As Predictors of Bladder Cancer Risk.